Pharmacovigilance as a Tool for Ensuring Economic Security in the Russian Healthcare System

DOI

10.2991/aebmr.k.210222.014How to use a DOI?

Keywords

pharmacovigilance, adverse reactions (ADR), drug safety, federal budget, safety monitoring, postmarketing research

Abstract

The article shows the role of the pharmacovigilance system for ensuring the economic security of the state by preventing and minimizing adverse reactions (ADRs) and side effects arising from the use of drugs. Important pharmacovigilance tools have been identified – the transmission of the received information about adverse reactions to medical and pharmaceutical specialists, as well as consumers to improve the quality of health care and patient safety in order to increase the economic efficiency of providing medical and pharmaceutical care to the population. As a result of the occurrence of undesirable reactions to the use of drugs, health deteriorates, additional treatment is required, in this regard, the recovery time and the cost of treatment increase. The growth of NR is associated with the supply from abroad of a large amount of different quality drugs, the presence of many generic drugs, which requires increased monitoring of drug safety in the post-registration period. Adverse reactions in the use of drugs in the treatment of rheumatoid arthritis were considered based on the results of monitoring of adverse reactions that occurred in patients in hospitals of the Novgorod region in the period from 2009 to 2018. To increase the participation of medical and pharmaceutical specialists in post-marketing monitoring of drug safety, it is necessary to effectively organize the participation of medical personnel: preparation of reports on the development of adverse reactions, increasing the attention of specialists regarding the safety of drug use and stimulating the transmission of messages about adverse reactions to drugs. One of the prerequisites for ensuring economic security is the availability of high-quality drug supply for the population, ensured through the competent distribution of federal budget funds, effective targeting and budgeting in the health care sector of the Russian Federation, as well as a pharmacovigilance system capable of detecting and preventing side effects and other problems associated with drugs.

Copyright

© 2021, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - G.A. Antropova
AU  - T.I. Okonenko
AU  - O.A. Fikhtner
AU  - V.R. Veber
AU  - O.D. Nemyatykh
PY  - 2021
DA  - 2021/02/24
TI  - Pharmacovigilance as a Tool for Ensuring Economic Security in the Russian Healthcare System
BT  - Proceedings of International Scientific and Practical Conference “Russia 2020 - a new reality: economy and society” (ISPCR 2020)
PB  - Atlantis Press
SP  - 68
EP  - 73
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.210222.014
DO  - 10.2991/aebmr.k.210222.014
ID  - Antropova2021
ER  -